纤维蛋白原在糖尿病及其并发症中的研究进展
Research Progress of Fibrinogen in Diabetes Mellitus and Its Complications
摘要: 糖尿病是由多病因引起的以血糖水平慢性升高为特征的代谢性疾病,长期慢性高血糖会对多器官造成损伤,从而导致多种并发症的发生,影响患者的生命健康。血浆纤维蛋白原(Fibrinogen, Fib)是由肝脏合成的表示机体处于急性时相的反应蛋白,是凝血级联反应中的关键成分,同时也有相关研究表明Fib与糖尿病及其多种并发症相关。本文将对Fib在糖尿病及其并发症中的相关研究展开综述。
Abstract: Diabetes mellitus (DM) is a metabolic disease characterized by chronic elevated blood glucose levels caused by multiple causes. Long-term chronic hyperglycemia will cause damage to multiple organs, resulting in a variety of complications and affecting the life and health of patients. Plasma fibrinogen (Fib) is a reactive protein synthesized by the liver indicating that the body is in the acute phase, which is a key component of the coagulation cascade. At the same time, related studies have shown that Fib is related to diabetes and its complications. This article will review the related research of Fib in diabetes mellitus and its complications.
文章引用:贾寒, 李晓冰, 芦勇铭, 忽胜和. 纤维蛋白原在糖尿病及其并发症中的研究进展[J]. 临床医学进展, 2021, 11(11): 5201-5206. https://doi.org/10.12677/ACM.2021.1111768

参考文献

[1] Mehravar, F., Mansournia, M.A., Holakouie-Naieni, K., et al. (2016) Associations between Diabetes Self-Management and Microvascular Complications in Patients with Type 2 Diabetes. Epidemiology and Health, 38, e2016004. [Google Scholar] [CrossRef
[2] Mauricio, D., Alonso, N. and Gratacos, M. (2020) Chronic Diabetes Complications: The Need to Move beyond Classical Concepts. Trends in Endocrinology & Metabolism, 31, 287-295. [Google Scholar] [CrossRef] [PubMed]
[3] Zadeh, F.J., Mohammadtaghizadeh, M., Bahadori, H., et al. (2020) The Role of Exogenous Fibrinogen in Cardiac Surgery: Stop Bleeding or Induce Cardiovascular Disease. Molecular Biology Reports, 47, 8189-8198. [Google Scholar] [CrossRef] [PubMed]
[4] Petersen, M.A., Ryu, J.K. and Akassoglou, K. (2018) Fibrinogen in Neurological Diseases: Mechanisms, Imaging and Therapeutics. Nature Reviews Neuroscience, 19, 283-301. [Google Scholar] [CrossRef] [PubMed]
[5] Lin, Y., Liu, Z., Qiu, Y., et al. (2018) Clinical Significance of Plasma D-Dimer and Fibrinogen in Digestive Cancer: A Systematic Review and Meta-Analysis. European Journal of Surgical Oncology, 44, 1494-1503. [Google Scholar] [CrossRef] [PubMed]
[6] Huang, G., Jiang, H., Lin, Y., et al. (2018) Prognostic Value of Plasma Fibrinogen in Hepatocellular Carcinoma: A Meta-Analysis. Cancer Management and Research, 10, 5027-5041. [Google Scholar] [CrossRef
[7] Koloverou, E., Panagiotakos, D.B., Georgousopoulou, E.N., et al. (2018) Single and Combined Effects of Inflammatory Markers on 10 Year Diabetes Incidence: The Mediating Role of Adiposity—Results from the ATTICA Cohort Study. Diabetes/Metabolism Research and Reviews, 34, 1-17. [Google Scholar] [CrossRef] [PubMed]
[8] Behl, T., Velpandian, T. and Kotwani, A. (2017) Role of Altered Coagulation-Fibrinolytic System in the Pathophysiology of Diabetic Retinopathy. Vascular Pharmacology, 92, 1-5. [Google Scholar] [CrossRef] [PubMed]
[9] Garcia-Carretero, R., Vigil-Medina, L. and Barquero-Perez, O. (2021) The Use of Machine Learning Techniques to Determine the Predictive Value of Inflammatory Biomarkers in the Development of Type 2 Diabetes Mellitus. Metabolic Syndrome and Related Disorders, 19, 240-248. [Google Scholar] [CrossRef] [PubMed]
[10] Alman, A.C., Talton, J.W., Wadwa, R.P., et al. (2018) Inflammation, Adiposity, and Progression of Arterial Stiffness in Adolescents with Type 1 Diabetes: The SEARCH CVD Study. Journal of Diabetes and its Complications, 32, 995-999. [Google Scholar] [CrossRef] [PubMed]
[11] Yuan, D., Jiang, P., Zhu, P., et al. (2021) Prognostic Value of Fibrinogen in Patients with Coronary Artery Disease and Prediabetes or Diabetes Following Percutaneous Coronary Intervention: 5-Year Findings from a Large Cohort Study. Cardiovascular Diabetology, 20, 143. [Google Scholar] [CrossRef] [PubMed]
[12] Agarwal, C., Bansal, K., Pujani, M., et al. (2019) Association of Coagulation Profile with Microvascular Complications and Glycemic Control in Type 2 Diabetes Mellitus—A Study at a Tertiary Care Center in Delhi. Hematology, Transfusion and Cell Therapy, 41, 31-36. [Google Scholar] [CrossRef] [PubMed]
[13] Abdul Razak, M.K. and Sultan, A.A. (2019) The Importance of Measurement of Plasma Fibrinogen Level among Patients with Type-2 Diabetes Mellitus. Diabetology & Metabolic Syndrome, 13, 1151-1158. [Google Scholar] [CrossRef] [PubMed]
[14] Bosevski, M., Bosevska, G., Stojanovska, L., et al. (2017) CRP and Fibrinogen Imply Clinical Outcome of Patients with Type-2 Diabetes and Coronary Artery Disease. Acta Biochimica et Biophysica Sinica (Shanghai), 49, 284-285. [Google Scholar] [CrossRef] [PubMed]
[15] Lee, S.J., Hong, J.M., Lee, S.E., et al. (2017) Association of Fibrinogen Level with Early Neurological Deterioration among Acute Ischemic Stroke Patients with Diabetes. BMC Neurology, 17, 101. [Google Scholar] [CrossRef] [PubMed]
[16] Yang, S.H., Du, Y., Zhang, Y., et al. (2017) Serum Fibrinogen and Cardiovascular Events in Chinese Patients with Type 2 Diabetes and Stable Coronary Artery Disease: A Prospective Observational Study. BMJ Open, 7, e015041. [Google Scholar] [CrossRef] [PubMed]
[17] Kotbi, S., Mjabber, A., Chadli, A., et al. (2016) Correlation between the Plasma Fibrinogen Concentration and Coronary Heart Disease Severity in Moroccan Patients with Type 2 Diabetes. Prospective Study. Annales d’Endocrinologie (Paris), 77, 606-614. [Google Scholar] [CrossRef] [PubMed]
[18] Rodrigues, T.C., Snell-Bergeon, J.K., Maahs, D.M., Kinney, G.L. and Rewers, M. (2010) Higher Fibrinogen Levels Predict Progression of Coronary Artery Calcification in Adults with Type 1 Diabetes. Atherosclerosis, 210, 671-673. [Google Scholar] [CrossRef] [PubMed]
[19] Wieczor, R., Wieczor, A.M., Kulwas, A., et al. (2019) Type 2 Diabetes and Cardiovascular Factors Contrasted with Fibrinolysis Disorders in the Blood of Patients with Peripheral Arterial Disease. Medicina (Kaunas), 55, 1-10. [Google Scholar] [CrossRef] [PubMed]
[20] Chen, Q.F., Cao, D., Ye, T.T., et al. (2018) Peripheral Arterial Disease in Type 2 Diabetes Is Associated with an Increase in Fibrinogen Levels. International Journal of Endocrinology, 2018, Article ID: 3709534. [Google Scholar] [CrossRef] [PubMed]
[21] Kearney, K., Tomlinson, D., Smith, K., et al. (2017) Hypofibrinolysis in Diabetes: A Therapeutic Target for the Reduction of Cardiovascular Risk. Cardiovascular Diabetology, 16, 34. [Google Scholar] [CrossRef] [PubMed]
[22] Sun, J. and Liu, C. (2018) Correlation of Vascular Endothelial Function and Coagulation Factors with Renal Function and Inflammatory Factors in Patients with Diabetic Nephropathy. Experimental and Therapeutic Medicine, 16, 4167-4171. [Google Scholar] [CrossRef] [PubMed]
[23] Pan, L., Ye, Y., Wo, M., et al. (2018) Clinical Significance of Hemostatic Parameters in the Prediction for Type 2 Diabetes Mellitus and Diabetic Nephropathy. Disease Markers, 2018, Article ID: 5214376. [Google Scholar] [CrossRef] [PubMed]
[24] Zhang, J., Wang, Y., Zhang, R., et al. (2018) Serum Fibrinogen Predicts Diabetic ESRD in Patients with Type 2 Diabetes Mellitus. Diabetes Research and Clinical Practice, 141, 1-9. [Google Scholar] [CrossRef] [PubMed]
[25] Rehman, S., Alouffi, S., Faisal, M., et al. (2021) Methylglyoxal Mediated Glycation Leads to Neo-Epitopes Generation in Fibrinogen: Role in the Induction of Adaptive Immune Response. International Journal of Biological Macromolecules, 175, 535-543. [Google Scholar] [CrossRef] [PubMed]
[26] Qin, Y.J., Chan, S.O., Lin, H.L., et al. (2020) Increased Expression of Growth Hormone-Releasing Hormone in Fibrinous Inflammation of Proliferative Diabetic Retinopathy. American Journal of Ophthalmology, 215, 81-90. [Google Scholar] [CrossRef] [PubMed]
[27] Wei, Q., Zhang, T., Jiang, R., et al. (2017) Vitreous Fibronectin and Fibrinogen Expression Increased in Eyes with Proliferative Diabetic Retinopathy after Intravitreal Anti-VEGF Therapy. Investigative Ophthalmology & Visual Science, 58, 5783-5791. [Google Scholar] [CrossRef] [PubMed]
[28] Huang, Q., Wu, H., Wo, M., et al. (2021) Clinical and Predictive Significance of Plasma Fibrinogen Concentrations Combined Monocyte-Lymphocyte Ratio in Patients with Diabetic Retinopathy. International Journal of Medical Sciences, 18, 1390-1398. [Google Scholar] [CrossRef] [PubMed]
[29] Pop-Busui, R., Boulton, A.J., Feldman, E.L., et al. (2017) Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care, 40, 136-154. [Google Scholar] [CrossRef] [PubMed]
[30] Zang, S., Shi, L., Zhao, J., et al. (2020) Prealbumin to Fibrinogen Ratio Is Closely Associated with Diabetic Peripheral Neuropathy. Endocrine Connections, 9, 858-863. [Google Scholar] [CrossRef
[31] Lin, C., Liu, J. and Sun, H. (2020) Risk Factors for Lower Extremity Amputation in Patients with Diabetic Foot Ulcers: A Meta-Analysis. PLoS ONE, 15, e0239236. [Google Scholar] [CrossRef] [PubMed]
[32] Li, X.H., Guan, L.Y., Lin, H.Y., et al. (2016) Fibrinogen: A Marker in Predicting Diabetic Foot Ulcer Severity. Journal of Diabetes Research, 2016, Article ID: 2358321. [Google Scholar] [CrossRef] [PubMed]
[33] Korkmaz, P., Kocak, H., Onbasi, K., et al. (2018) The Role of Serum Procalcitonin, Interleukin-6, and Fibrinogen Levels in Differential Diagnosis of Diabetic Foot Ulcer Infection. Journal of Diabetes Research, 2018, Article ID: 7104352. [Google Scholar] [CrossRef] [PubMed]